Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients
Launched by ADVENTHEALTH UNIVERSITY · Mar 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how using a wearable activity tracker, like a Fitbit, can help people in Phase III Cardiac Rehabilitation (CR) increase their physical activity and improve their overall well-being. The study will track how many steps participants take and their sleep patterns over eight weeks. The goal is to see if this technology encourages participants to be more active and to understand how it affects their sleep, physical ability, and quality of life.
To take part in the study, you need to be at least 18 years old, currently participating in Phase III CR at Hope Clinic, and able to read and communicate in English. You'll also need a smartphone that can send and receive text messages and be comfortable wearing the Fitbit during the study. Participants will receive text messages and phone calls from the research team for support. However, if you are pregnant, have upcoming surgery, or are very active already, you wouldn't be eligible for this trial. This study could provide valuable insights into how technology can support heart health and encourage a more active lifestyle.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • currently receiving Phase III CR at Hope Clinic
- • are 18 years of age or older
- • can read and communicate in English
- • able to follow instructions to walk
- • provided signed informed consent
- • willing to wear Fitbit throughout the study
- • owns a smartphone with text messaging capability (participants need to decide ahead of time if they have a phone plan that is compatible with taking additional text messages without undue financial burden for themselves)
- • willing to receive text messages and phone calls from the research team.
- Exclusion Criteria:
- • are pregnant or lactating
- • have scheduled surgery or traveling within the next 8 weeks
- • currently participating in other health promotion program
- • sufficiently or overly active, as determined by a physical activity monitor worn for one week, indicating averaging ≥ 7,500 steps per day ("somewhat overly active").
About Adventhealth University
AdventHealth University is a leading institution dedicated to advancing healthcare education and clinical research. As a sponsor of clinical trials, the university leverages its commitment to innovation and excellence in patient care to facilitate groundbreaking studies that contribute to the improvement of health outcomes. With a strong focus on interdisciplinary collaboration, AdventHealth University engages in research initiatives that explore new therapies and treatment modalities, ensuring the integration of evidence-based practices into clinical settings. The university's experienced team of researchers and healthcare professionals is dedicated to upholding the highest ethical standards while fostering an environment of academic inquiry and discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials